Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lais da Silva

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Pharmacotherapy|May 15, 2025
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populationsAditi Shendre, Xiaofu Liu, ChienWei Chiang, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
NPJ Vaccines|April 27, 2026
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
Vaccines|April 3, 2021
Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against MalariaJoseph R Francica, Wei Shi, Gwo-Yu Chuang, et al.
The Journal of Experimental Medicine|June 23, 2022
Highly protective antimalarial antibodies via precision library generation and yeast display screeningBailey B Banach, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Iscience|July 18, 2025
<i>In silico</i> improvement of affinity for highly protective anti-malarial antibodiesMateo Reveiz, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Immunity|November 17, 2021
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodiesSven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, et al.
Frontiers in Endocrinology|December 12, 2022
Global miRNA expression reveals novel nuclear and mitochondrial interactions in Type 1 diabetes mellitusRafaella Sousa Ferraz, Lucas Cauê Bezerra Santos, Rebecca Lais da-Silva-Cruz, et al.
Journal of Medicinal Chemistry|April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Pharmacotherapy|May 15, 2025
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populationsAditi Shendre, Xiaofu Liu, ChienWei Chiang, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
NPJ Vaccines|April 27, 2026
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
Vaccines|April 3, 2021
Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against MalariaJoseph R Francica, Wei Shi, Gwo-Yu Chuang, et al.
The Journal of Experimental Medicine|June 23, 2022
Highly protective antimalarial antibodies via precision library generation and yeast display screeningBailey B Banach, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Iscience|July 18, 2025
<i>In silico</i> improvement of affinity for highly protective anti-malarial antibodiesMateo Reveiz, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.
Immunity|November 17, 2021
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodiesSven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, et al.
Frontiers in Endocrinology|December 12, 2022
Global miRNA expression reveals novel nuclear and mitochondrial interactions in Type 1 diabetes mellitusRafaella Sousa Ferraz, Lucas Cauê Bezerra Santos, Rebecca Lais da-Silva-Cruz, et al.
Journal of Medicinal Chemistry|April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Pageof 4